LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study-Reference-Cited by-同舟云学术

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study

Published:2018-08 Issue: Volume:264 Page:172-178
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Pichler G.,Amigo N.,Tellez-Plaza M.,Pardo-Cea M.A.,Dominguez-Lucas A.,Marrachelli V.G.,Monleon D.,Martin-Escudero J.C.,Ascaso J.F.,Chaves F.J.,Carmena R.,Redon J.

Funder

Strategic Action for Research in Health Sciences

Valencia Government

Spanish Ministry of Economy and Competitiveness

Castilla-Leon Government

CIBER Fisiopatología Obesidad y Nutrición

CIBER de Diabetes y Enfermedades Metabólicas Relacionadas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL;Hevonoja;Biochim. Biophys. Acta,2000

2. A comparative study of four independent methods to measure LDL particle concentration;Hopkins;Atherosclerosis,2015

3. Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease;Williams;Atherosclerosis,2014

4. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy;Mallol;J. Lipid Res.,2015

5. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis;Jellinger;Endocr. Pract.,2012

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicle and lipoprotein diagnostics (ExoLP-Dx) with membrane sensor: A robust microfluidic platform to overcome heterogeneity;Biomicrofluidics;2024-07-01

2. Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease;Medicina Clínica;2024-05

3. Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease;Medicina Clínica (English Edition);2024-05

4. Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases;Progress in Cardiovascular Diseases;2024-03

5. The association of appendicular lean mass and grip strength with low-density lipoprotein, very low-density lipoprotein, and high-density lipoprotein particle diameter: a Mendelian randomization study of the UK Biobank cohort;European Heart Journal Open;2024-03-01